Vitruvias Therapeutics Inc.
34 drugs in NADAC|34 Generic,0 Brand
Vitruvias Therapeutics Inc. lists 34 NDCs in the CMS NADAC file (34 generic, 0 brand), at an average NADAC of $2.15 per unit, with a week-over-week move of -2.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
34
34G / 0B
Avg Price / Unit
$2.1545
$0.08 – $9.54
Avg 7d Change
-2.34%
Across 31 drugs with changes
7d Activity
of 34 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Cyanocobalamin market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
N-methyl-D-aspartate Receptor Antagonist therapeutic class
Review the broader class where Vitruvias Therapeutics Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Vitruvias Therapeutics Inc. make?
Vitruvias Therapeutics Inc. lists 34 NDCs in the CMS NADAC file — 34 generic and 0 brand products.
What is the average price of Vitruvias Therapeutics Inc. drugs?
The average NADAC across Vitruvias Therapeutics Inc.'s portfolio is $2.1545 per unit, ranging from $0.0785 to $9.5420.
What types of drugs does Vitruvias Therapeutics Inc. make?
Vitruvias Therapeutics Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are N-methyl-D-aspartate Receptor Antagonist (6), Vitamin B12 (6), Antifibrinolytic Agent (3), Antiarrhythmic (3), Aminoketone (3).
Has Vitruvias Therapeutics Inc. had any drug recalls?
No FDA enforcement recalls are matched to Vitruvias Therapeutics Inc. in the openFDA feed.
How has Vitruvias Therapeutics Inc.'s pricing changed recently?
Over the past 7 days, 10 Vitruvias Therapeutics Inc. products rose and 21 fell, with a portfolio-wide average change of -2.3%.